Sort   by:  
 Page size 
UnknownThe prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma.
Not available
S-EPMC5352439 | biostudies-literature
UnknownMulticenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma.
Not available
S-EPMC3659946 | biostudies-literature
UnknownUpdates in the Treatment of Peripheral T-Cell Lymphomas.
Not available
S-EPMC8235949 | biostudies-literature
UnknownPhase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma.
Not available
S-EPMC5791843 | biostudies-literature
TranscriptomicsComparative genomic hybridization of human Burkitts lymphoma samples
Additional chromosomal abnormalities are currently detected in Burkitt’s lymphoma. They play major roles in the progression of BL and in prognosis. The genes involved remain elusive. A whole-genome oligonucleotide array CGH analysis correlated with karyotype and FISH was performed in a set of 15 Bu...
ORGANISM(S): Homo sapiens 
2009-09-18 | E-TABM-703 | biostudies-arrayexpress
UnknownTumor Microenvironment and Immunotherapy-Based Approaches in Mantle Cell Lymphoma.
Not available
S-EPMC9265015 | biostudies-literature
UnknownBMP7 expression correlates with secondary drug resistance in mantle cell lymphoma.
Not available
S-EPMC3771972 | biostudies-literature
UnknownCAR T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia.
Not available
S-EPMC10647582 | biostudies-literature
TranscriptomicsIGR_CamaraClayette_MCL
We designed a gene profiling experiment to identify genes involved in secondary drug resistance in mantle cell lymphomas (MCL). We obtained paired tissue samples collected before treatment and after relapse or progression. Variations in gene expression between the 2 samples were estimated for 5 pati...
ORGANISM(S): Homo sapiens 
2013-01-17 | E-MTAB-1090 | biostudies-arrayexpress
UnknownKEYNOTE-013 4-year follow-up of pembrolizumab in classical Hodgkin lymphoma after brentuximab vedotin failure.
Not available
S-EPMC7322954 | biostudies-literature
Sort   by:  
 Page size